Baidu
map

NAT STRUCT MOL BIOL:麻疹病毒侵入上皮细胞机制研究获进展

2012-12-07 高福等 《自然—结构和分子生物学》

  麻疹病毒(measles virus, MV)是引起小儿麻疹的元凶。据世卫组织(World Health Organization)统计,全球每年有约2000万儿童罹患麻疹,仅2010年就有约139300患儿死于麻疹病毒感染。麻疹病毒传染性强,发病率高,除引起常见的咳嗽,高烧,恐光和遍及面部、躯干和上肢的皮疹外,还易与支气管肺炎或脑膜炎等并发,造成很高的死亡率。虽然麻疹疫苗可以有效控制麻疹病毒

  麻疹病毒(measles virus, MV)是引起小儿麻疹的元凶。据世卫组织(World Health Organization)统计,全球每年有约2000万儿童罹患麻疹,仅2010年就有约139300患儿死于麻疹病毒感染。麻疹病毒传染性强,发病率高,除引起常见的咳嗽,高烧,恐光和遍及面部、躯干和上肢的皮疹外,还易与支气管肺炎或脑膜炎等并发,造成很高的死亡率。虽然麻疹疫苗可以有效控制麻疹病毒的感染和传播,但麻疹疫苗并不完美,不仅在疫苗覆盖率低的国家和地区,甚至在高覆盖率的欧美等国家和中国,麻疹仍然是造成小儿死亡的主因之一。

  麻疹病毒属副黏病毒科,呈球形,为具囊膜的负链RNA病毒。病毒囊膜上含有血凝素(Hemagglutinin, H)蛋白,介导对宿主特异性受体分子的结合,是起始病毒对细胞感染的最重要的分子。细胞粘附分子家族成员nectin-4新近被鉴定为麻疹病毒在上皮细胞的受体,成为继SLAM和CD46之后,麻疹病毒的第三个受体分子。但CD46只被麻疹疫苗株识别;作为致病毒株的受体,nectin-4较SLAM具有更为广泛的组织和器官分布。因此,鉴定MV H蛋白与nectin-4的结合模式,对于麻疹病毒侵入机制研究和有效药物靶点的发现具有重要意义。

  中科院微生物研究所高福课题组长期致力于囊膜病毒跨种间传播机制与免疫分子识别研究,针对新发现的病毒受体分子,迅速开展了复合物结构及相互作用的功能研究。高福课题组张晓爱、逯光文等研究人员成功制备了高纯度的MV H与nectin-4的蛋白复合物,获得了高质量的晶体,并解析了复合物的分子结构。MV H蛋白为六个类螺旋桨叶(β1-β6)组成的方形结构;nectin-4分子通过自身的第一个免疫球蛋白样结构域(immunoglobulin-like domain)结合于H蛋白的β4和β5桨叶片之间的沟槽内;两个分子间以疏水相互作用为主。在nectin-4与MV H的结合界面上,nectin-4分子通过F-G loop顶端的Phe-Pro双残基基序插入到H蛋白一个高度疏水的口袋中,在MV H与nectin-4的结合和介导病毒侵入中发挥关键作用。

  进一步的比较分析发现,这一疏水口袋在MV H对另外两个受体SLAM和CD46的结合中也具有非常重要的作用。这提示以该口袋为靶点设计小分子药物,可以有效阻断麻疹病毒对现已鉴定的所有受体分子的结合。

  麻疹对公共卫生安全的潜在威胁亟需特异、高效的抗麻疹病毒药物。阻断病毒的结合和侵入,防患于未然,是最有效的抗病毒手段之一。课题组对MV H和nectin-4结合模式的研究成果,对抗麻疹病毒的药物设计具有重要的指导意义。

  该项研究成果近期发表在自然子刊Nature Structural &Molecular Biology杂志上。




Abstract
Measles virus is a major public health concern worldwide. Three measles virus cell receptors have been identified so far, and the structures of the first two in complex with measles virus hemagglutinin (MV-H) have been reported. Nectin-4 is the most recently identified receptor in epithelial cells, and its binding mode to MV-H remains elusive. In this study, we solved the structure of the membrane-distal domain of human nectin-4 in complex with MV-H. The structure shows that nectin-4 binds the MV-H β4-β5 groove exclusively via its N-terminal IgV domain; the contact interface is dominated by hydrophobic interactions. The binding site in MV-H for nectin-4 also overlaps extensively with those of the other two receptors. Finally, a hydrophobic pocket centered in the β4-β5 groove is involved in binding to all three identified measles virus receptors, representing a potential target for antiviral drugs.                

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
    2013-02-27 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
    2013-05-28 liye789132251
  5. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
    2013-09-21 日月
  6. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
    2013-07-03 wjywjy
  7. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]
    2012-12-09 zhaojie88
  10. [GetPortalCommentsPageByObjectIdResponse(id=1801183, encodeId=6eaa1801183f7, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 16 23:40:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056110, encodeId=b35e2056110cc, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 13 12:40:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916929, encodeId=941b191692970, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Feb 27 20:40:00 CST 2013, time=2013-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879384, encodeId=0ee518e938413, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 28 05:40:00 CST 2013, time=2013-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795119, encodeId=1f171e95119cd, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Sep 21 14:40:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822466, encodeId=b7f71822466ab, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jul 03 04:40:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766809, encodeId=d68d1e6680973, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Aug 25 19:40:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033609, encodeId=d4f9203360942, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Tue Jan 22 13:40:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355542, encodeId=f9a5135554277, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533804, encodeId=817015338048d, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Sun Dec 09 05:40:00 CST 2012, time=2012-12-09, status=1, ipAttribution=)]

相关资讯

国家消除麻疹证实委员会成立

  国家消除麻疹证实委员会日前成立。该委员会委员由中国疾控中心、北京医院、北京地坛医院、北京生物制品研究所等单位的多领域专家组成,主要职责是按照消除麻疹证实工作的要求,评估证实准备情况,监督指导证实过程,审核确认国家消除麻疹文件和报告,适时向世界卫生组织西太区消除麻疹证实委员会提出我国消除麻疹证实申请。   麻疹是一种严重危害儿童健康的急性呼吸道传染病,传染性极强,易引起暴发流行。麻疹病毒只有一

Baidu
map
Baidu
map
Baidu
map